breast cancer

Research in Review

High-Priority Areas for Quality Improvement Identified for Breast Cancer Treatment

07/26/2017

JCP Editors

Researchers identified three quality measures that have the largest potential of improving quality of care at a system level for patients with early-stage breast cancer receiving systemic therapy. ----- Related...

...

07/26/2017

Journal of Clinical Pathways

Research in Review

Neoadjuvant Chemotherapy May Induce Breast Cancer Metastasis

07/10/2017

JCP Editors

A neoadjuvant chemotherapy combination used to treat breast cancer increases the risk of disease metastasis, according to recent research published in Science Translational Medicine (published online July 5, 2017;...

A...

07/10/2017

Journal of Clinical Pathways

Research in Review

Adjuvant Ovarian Function Suppression Improves Breast Cancer Treatment Outcomes

06/29/2017

JCP Editors

In younger women with hormone receptor (HR)-positive breast cancer, ovarian function suppression (OFS) after surgery drives large improvements in breast cancer-free interval when combined with drug therapy, according...

In...

06/29/2017

Journal of Clinical Pathways

Research in Review

Cost-Effective Substitute for Breast Cancer MRI Identified

06/26/2017

JCP Editors

A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast magnetic resonance imaging (MRI), published in the American Journal of Roentgenology (June...

A...

06/26/2017

Journal of Clinical Pathways

Research in Review

Recent Breast Cancer HER2 Testing Guideline Update Produces Similar Positivity Rate

06/14/2017

JCP Editors

Updates to the 2013 human epidermal growth factor receptor 2 (HER2) testing guideline in breast cancer did not affect the overall positivity rate or the proportion of patients eligible for targeted therapy, according...

...

06/14/2017

Journal of Clinical Pathways

Research in Review

Brain Metastases Resistant to Targeted Therapy Due to Gene Overexpression

06/14/2017

JCP Editors

A novel mechanism responsible for brain metastasis resistance to targeted therapy has been identified, which may help guide treatment strategies, according to a study published in Science Translational Medicine...

A...

06/14/2017

Journal of Clinical Pathways

Research in Review

Panel Highlights Uses of Genomic Testing for Breast Cancer

06/07/2017

JCP Editors

A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...

A...

06/07/2017

Journal of Clinical Pathways

Research in Review

Metastatic Breast Cancer Study Recruits Patients Via Social Media

06/04/2017

JCP Editors

A direct-to-patient approach has allowed the Metastatic Breast Cancer Project (MCBP) research study to identify nearly 3000 patients willing to provide medical records and tumor samples for analysis, according to...

A...

06/04/2017

Journal of Clinical Pathways

Research in Review

Financial Burden for Patients With Early-Stage Breast Cancer After Surveillance Testing

05/31/2017

JCP Editors

Women who have been treated for early-stage breast cancer and receive surveillance testing are at risk of adverse events and increased financial burden, according to research that will be presented at the 2017 ASCO...

Women...

05/31/2017

Journal of Clinical Pathways

Research in Review

Breast Cancer HER2 Status Conversion After Neoadjuvant Chemo Guides Further Therapy

05/30/2017

JCP Editors

Patients with human epidermal growth factor 2 (HER2)-positive breast cancer who undergo induction chemotherapy are likely to convert to HER2-negative disease if residual disease occurs, prompting further systemic...

...

05/30/2017

Journal of Clinical Pathways